Organization and Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Jul. 09, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Cash and Cash Equivalent | $ 17,392 | $ 27,136 | |
| Subsequent Event | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Proceeds from issuance of private placement of pre-funded warrants and common stock warrants | $ 49,800 | ||
| Collaboration and License Agreement With Ascendant Health Sciences Ltd [Member] | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Cash outflows related to upfront payment to Ascendant, and other one-time legal fees, consulting fees and employee related costs | $ 28,000 |